<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A clinico-pathological study was carried out in two series of patients in order to determine: the prevalence of <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> in <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> in patients undergoing surgical resection for columnar <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> of the oesophagus, the incidence of <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> in patients with complications of <z:e sem="disease" ids="C0017168" disease_type="Disease or Syndrome" abbrv="GERD">gastro-oesophageal reflux</z:e>, and the subsequent <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> development in 3-20 years follow-up of such patients, compared with others who had no <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Group 1 consisted of 264 patients with <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> of the oesophagus undergoing resection and reconstruction; 18 (6.8%) had concomitant <z:mp ids='MP_0002038'>carcinoma</z:mp> and <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>These were predominantly male (male/female ratio 8/1) and had worse long-term survival than the other <z:mp ids='MP_0009308'>adenocarcinomas</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>Group 2 consisted of 782 patients with complications of <z:e sem="disease" ids="C0017168" disease_type="Disease or Syndrome" abbrv="GERD">gastro-oesophageal reflux</z:e>, 26 (3.3%) of whom were found to have <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>When followed up for a period of up to 20 years, 4 (15.4%) of these developed <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> in the mean period of 11.5 years (1 case per 74 person-years) </plain></SENT>
<SENT sid="5" pm="."><plain>This is highly significant compared with 4 others (0.5%) who developed <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> amongst the 756 remaining patients in group 2 with no <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e>, in the mean interval of 8 years 2 months (1 case per over 1500 person-years) </plain></SENT>
<SENT sid="6" pm="."><plain>Of the 18 patients with Barrett's stricture, 4 (22%) developed <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> at a mean interval of 11.5 years representing one case per 51.7 person-years indicating a higher risk of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> development in patients with Barrett's stricture compared with other patients with complications of <z:e sem="disease" ids="C0017168" disease_type="Disease or Syndrome" abbrv="GERD">gastro-oesophageal reflux</z:e> with/without columnar epithelial-lined oesophagus and no stricture </plain></SENT>
<SENT sid="7" pm="."><plain>Anti-reflux operation has not protected our patients with <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> against <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> development </plain></SENT>
</text></document>